I'm letting the board run up a coupla 300 posts, cuz the hard part is done. This also tempers my participation since many of the threads are stale by the time I get to them. Some are years stale by repetition. But sometimes they make my eye water and my brain hurt.
V is a prescription drug with a newly acquired CVD label with as of this moment, not enough insurance coverage. It is not saving or extending nearly enough lives.
Amarin has to stick with the label. Patients will see the commercials and want it. Physicians will prescribe as they see fit. If a patient doesn't find the right physician the first time they will find it the second. People currently taking Vascepa know the drill to get a prescription and it will soon be much easier once insurance companies start covering it. Amarin can't use the cardiac candy or liquid stent conversation but we can.